Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 20 results

Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study

research Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study

November 2025 in “Mendeley Data”

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Low-Dose Oral Minoxidil for Androgenetic Alopecia Is Not Associated With Blood Pressure Changes in Patients Also Taking Other Antihypertensive Medications: A Multi-Center Cohort Study Using TriNetX

research Low-Dose Oral Minoxidil for Androgenetic Alopecia Is Not Associated With Blood Pressure Changes in Patients Also Taking Other Antihypertensive Medications: A Multi-Center Cohort Study Using TriNetX

March 2025 in “Journal of the American Academy of Dermatology”

Low-dose oral minoxidil doesn't affect blood pressure in patients taking blood pressure meds.

research The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study

December 2025 in “Cureus”

research Increased Risk of Telogen Effluvium with Tirzepatide Compared to Other Weight-Loss Medications: A Retrospective Cohort TriNetX Database Study

August 2025 in “Journal of the American Academy of Dermatology”

research Semaglutide and Hair Loss: A Real-World Analysis

September 2024 in “Journal of the American Academy of Dermatology”

Semaglutide does not significantly increase the risk of hair loss.

View more "trinetx" in research →

Community Join

1 / 1 results

community Sexual Dysfunction in Those with Androgenetic Alopecia on Dutasteride Versus Finasteride

in Finasteride/Dutasteride 113 upvotes 6 months ago

Dutasteride and finasteride have similar risks of sexual dysfunction for treating androgenetic alopecia. Users experience varying side effects, indicating individual differences in drug reactions.